Lab
|
Normal
|
ASC-US
|
LSIL
|
ASC-H
|
HSIL
|
---|
OUS
|
86.9
|
5.0
|
0.9
|
1.0
|
1.1
|
Lab for pat/Furst
|
92.62
|
3.03
|
0.7
|
0.5
|
0.63
|
HUS1
|
83.6
|
5.0
|
2.4
|
0.8
|
1.42
|
St.Olav1
|
84.0
|
8.02
|
1.1
|
1.82
|
1.1
|
Molde
|
86.6
|
2.9
|
1.0
|
0.4
|
1.1
|
Gyn lab/unilabs
|
89.9
|
4.9
|
0.8
|
0.7
|
0.63
|
Østfold
|
87.0
|
4.6
|
0.9
|
0.9
|
0.8
|
UNN
|
79.23
|
4.8
|
4.62
|
1.42
|
1.1
|
Telemark
|
88.7
|
3.2
|
2.3
|
0.3
|
1.0
|
Innlandet,Lillehammer
|
93.02
|
3.4
|
0.9
|
0.6
|
0.6
|
Vestre Viken
|
91.1
|
3.6
|
1.8
|
0.6
|
0.9
|
Ålesund
|
91.42
|
5.1
|
1.4
|
0.5
|
0.63
|
Nordland
|
86.4
|
3.6
|
1.9
|
1.1
|
0.8
|
SUS1
|
84.6
|
4.9
|
2.5
|
0.6
|
1.32
|
Sørlandet
|
89.1
|
3.0
|
1.1
|
0.7
|
0.8
|
AHUS
|
93.42
|
2.5
|
1.5
|
0.8
|
1.0
|
Vestfold
|
83.0
|
8.52
|
2.1
|
2.02
|
0.9
|
Total
|
88.1
|
4.3
|
1.6
|
0.9
|
0.9
|
- Adapted from the Norwegian Cancer Screening Programme – annual report 2015 [5]
-
1Laboratories included in HPV primary screening pilot where women 34 years and older are randomized to Pap smear every three years or HPV test every five years
-
2Significantly higher than the average for Norway (p<0.05)
-
3Significantly lower than the average for Norway (p<0.05)